Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IgA-Mediated Killing of Tumor Cells by Neutrophils Is Enhanced by CD47–SIRPα Checkpoint Inhibition
Louise W. Treffers, Toine ten Broeke, Thies Rösner, et al.
Cancer Immunology Research (2019) Vol. 8, Iss. 1, pp. 120-130
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Neutrophil diversity and plasticity in tumour progression and therapy
Sébastien Jaillon, Andrea Ponzetta, Diletta Di Mitri, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 9, pp. 485-503
Closed Access | Times Cited: 836
Neutrophils in cancer carcinogenesis and metastasis
Shu-Min Xiong, Liaoliao Dong, Lin Cheng
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 331
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets
Yan Tie, Fan Tang, Yuquan Wei, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 279
Tumor-associated myeloid cells: diversity and therapeutic targeting
Alberto Mantovani, Federica Marchesi, Sébastien Jaillon, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 3, pp. 566-578
Open Access | Times Cited: 148
Exploiting innate immunity for cancer immunotherapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 70
Neutrophils at the Crossroads: Unraveling the Multifaceted Role in the Tumor Microenvironment
Deepika Awasthi, Aditya Sarode
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2929-2929
Open Access | Times Cited: 15
Neutrophil dynamics in the tumor microenvironment
Amanda J. McFarlane, Frédéric Fercoq, Seth B. Coffelt, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 6
Open Access | Times Cited: 85
Tumor-Associated Neutrophils in Hepatocellular Carcinoma Pathogenesis, Prognosis, and Therapy
Konstantinos Arvanitakis, Ioannis Mitroulis, Georgios Germanidis
Cancers (2021) Vol. 13, Iss. 12, pp. 2899-2899
Open Access | Times Cited: 84
Plasticity in Pro- and Anti-tumor Activity of Neutrophils: Shifting the Balance
Charita Furumaya, Paula Martínez-Sanz, Panagiota Bouti, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 81
CD47/SIRPα axis: bridging innate and adaptive immunity
Anneloes van Duijn, Sjoerd H. van der Burg, Ferenc A. Scheeren
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 7, pp. e004589-e004589
Open Access | Times Cited: 65
N1 versus N2 and PMN‐MDSC: A critical appraisal of current concepts on tumor‐associated neutrophils and new directions for human oncology
Benedict Boateng Antuamwine, Rebeka Bosnjakovic, Francisca Hofmann‐Vega, et al.
Immunological Reviews (2022) Vol. 314, Iss. 1, pp. 250-279
Open Access | Times Cited: 45
The CD47-SIRPα axis is a promising target for cancer immunotherapies
Hao Yu, Xinxuan Zhou, Yiling Li, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110255-110255
Closed Access | Times Cited: 32
Cross-Talk among Polymorphonuclear Neutrophils, Immune, and Non-Immune Cells via Released Cytokines, Granule Proteins, Microvesicles, and Neutrophil Extracellular Trap Formation: A Novel Concept of Biology and Pathobiology for Neutrophils
Chang‐Youh Tsai, Song‐Chou Hsieh, Chih‐Wei Liu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 3119-3119
Open Access | Times Cited: 51
Augmented antibody-based anticancer therapeutics boost neutrophil cytotoxicity
Niels Heemskerk, Mandy Gruijs, A. Robin Temming, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 6
Open Access | Times Cited: 43
Neutrophil interactions with T cells, platelets, endothelial cells, and of course tumor cells
Brahm H. Segal, Thejaswini Giridharan, Sora Suzuki, et al.
Immunological Reviews (2022) Vol. 314, Iss. 1, pp. 13-35
Open Access | Times Cited: 29
Neutrophils as immune effector cells in antibody therapy in cancer
Leonie M. Behrens, Marjolein van Egmond, Timo K. van den Berg
Immunological Reviews (2022) Vol. 314, Iss. 1, pp. 280-301
Open Access | Times Cited: 28
Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells
Marta Lustig, Chilam Chan, J.H. Marco Jansen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Complement activation drives antibody-mediated transfusion-related acute lung injury via macrophage trafficking and formation of NETs
Saskia van der Velden, Thijs L. J. van Osch, Amina Seghier, et al.
Blood (2023) Vol. 143, Iss. 1, pp. 79-91
Closed Access | Times Cited: 16
Human tumor-associated macrophages and neutrophils regulate anti-tumor antibody efficacy through lethal and sublethal trogocytosis
Sunil Singhal, Abhishek S. Rao, Jason Stadanlick, et al.
Cancer Research (2024) Vol. 84, Iss. 7, pp. 1029-1047
Open Access | Times Cited: 6
Immune Microenvironment in Breast Cancer Metastasis
Bin‐Zhi Qian, Ruoyu Ma
Advances in experimental medicine and biology (2025), pp. 413-432
Closed Access
Engineering of anti-cancer human IgA equipped with albumin for enhanced plasma half-life
Simone Mester, Chilam Chan, Marta Lustig, et al.
PNAS Nexus (2025)
Open Access
Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy
Fatemeh Sadat Toghraie, Maryam Bayat, Mahsa Sadat Hosseini, et al.
Cellular Oncology (2025)
Open Access
When Therapeutic IgA Antibodies Might Come of Age
Delphine Sterlin, Guy Gorochov
Pharmacology (2020) Vol. 106, Iss. 1-2, pp. 9-19
Open Access | Times Cited: 41
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids
Firas Hamdan, Erkko Ylösmäki, Jacopo Chiaro, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 8, pp. e003000-e003000
Open Access | Times Cited: 37
The dual role of neutrophils in cancer
Merav E. Shaul, Zvi G. Fridlender
Seminars in Immunology (2021) Vol. 57, pp. 101582-101582
Closed Access | Times Cited: 37
Page 1 - Next Page

Scroll to top